234 related articles for article (PubMed ID: 23629521)
21. A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9.
Goos JA; Coupé VM; van de Wiel MA; Diosdado B; Delis-Van Diemen PM; Hiemstra AC; de Cuba EM; Beliën JA; Menke-van der Houven van Oordt CW; Geldof AA; Meijer GA; Hoekstra OS; Fijneman RJ;
Oncotarget; 2016 Jan; 7(2):2123-34. PubMed ID: 26497206
[TBL] [Abstract][Full Text] [Related]
22. PTGS2 (Cyclooxygenase-2) expression and survival among colorectal cancer patients: a systematic review.
Kunzmann AT; Murray LJ; Cardwell CR; McShane CM; McMenamin UC; Cantwell MM
Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1490-7. PubMed ID: 23810915
[TBL] [Abstract][Full Text] [Related]
23. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.
Liao X; Lochhead P; Nishihara R; Morikawa T; Kuchiba A; Yamauchi M; Imamura Y; Qian ZR; Baba Y; Shima K; Sun R; Nosho K; Meyerhardt JA; Giovannucci E; Fuchs CS; Chan AT; Ogino S
N Engl J Med; 2012 Oct; 367(17):1596-606. PubMed ID: 23094721
[TBL] [Abstract][Full Text] [Related]
24. Investigation of β-catenin and E-cadherin expression in Dukes B2 stage colorectal cancer with tissue microarray method. Is it a marker of metastatic potential in rectal cancer?
Tóth L; András C; Molnár C; Tanyi M; Csiki Z; Molnár P; Szántó J
Pathol Oncol Res; 2012 Apr; 18(2):429-37. PubMed ID: 21975680
[TBL] [Abstract][Full Text] [Related]
25. SMO expression in colorectal cancer: associations with clinical, pathological, and molecular features.
Li T; Liao X; Lochhead P; Morikawa T; Yamauchi M; Nishihara R; Inamura K; Kim SA; Mima K; Sukawa Y; Kuchiba A; Imamura Y; Baba Y; Shima K; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S; Qian ZR
Ann Surg Oncol; 2014 Dec; 21(13):4164-73. PubMed ID: 25023548
[TBL] [Abstract][Full Text] [Related]
26. Over-expression of the overexpressed in lung cancer-1 is associated with poor prognosis in colorectal cancer.
Liu J; Song H; Yao L; Liu Y; Zhang Y; Zhao H; Ji H; Wang Y
Anticancer Res; 2014 Jan; 34(1):367-72. PubMed ID: 24403489
[TBL] [Abstract][Full Text] [Related]
27. High PTGS2 expression in post-neoadjuvant chemotherapy-treated oesophageal adenocarcinoma is associated with improved survival: a population-based cohort study.
Spence AD; Trainor J; McMenamin Ú; Turkington RC; McQuaid S; Bingham V; James J; Salto-Tellez M; McManus DT; Johnston BT; Cardwell CR; Coleman HG
Histopathology; 2019 Mar; 74(4):587-596. PubMed ID: 30408225
[TBL] [Abstract][Full Text] [Related]
28. Associations of alcohol intake, smoking, physical activity and obesity with survival following colorectal cancer diagnosis by stage, anatomic site and tumor molecular subtype.
Jayasekara H; English DR; Haydon A; Hodge AM; Lynch BM; Rosty C; Williamson EJ; Clendenning M; Southey MC; Jenkins MA; Room R; Hopper JL; Milne RL; Buchanan DD; Giles GG; MacInnis RJ
Int J Cancer; 2018 Jan; 142(2):238-250. PubMed ID: 28921583
[TBL] [Abstract][Full Text] [Related]
29. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of TP53 protein is associated with the lack of adjuvant chemotherapy benefit in patients with stage III colorectal cancer.
Williams DS; Mouradov D; Browne C; Palmieri M; Elliott MJ; Nightingale R; Fang CG; Li R; Mariadason JM; Faragher I; Jones IT; Churilov L; Tebbutt NC; Gibbs P; Sieber OM
Mod Pathol; 2020 Mar; 33(3):483-495. PubMed ID: 31471586
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological predictors of benefit from adjuvant chemotherapy for stage C colorectal cancer: Microsatellite unstable cases benefit.
Thomas ML; Hewett PJ; Ruszkiewicz AR; Moore JW
Asia Pac J Clin Oncol; 2015 Dec; 11(4):343-51. PubMed ID: 26471980
[TBL] [Abstract][Full Text] [Related]
32. The prognostic significance of WNT pathway in surgically-treated colorectal cancer: β-catenin expression predicts for disease-free survival.
Kamposioras K; Konstantara A; Kotoula V; Lakis S; Kouvatseas G; Akriviadis E; Vrettou E; Dionysopoulos D; Krikelis D; Papadopoulou K; Charalambous E; Chrisafi S; Konstantaras C; Fountzilas G
Anticancer Res; 2013 Oct; 33(10):4573-84. PubMed ID: 24123033
[TBL] [Abstract][Full Text] [Related]
33. Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer.
Ogino S; Kirkner GJ; Nosho K; Irahara N; Kure S; Shima K; Hazra A; Chan AT; Dehari R; Giovannucci EL; Fuchs CS
Clin Cancer Res; 2008 Dec; 14(24):8221-7. PubMed ID: 19088039
[TBL] [Abstract][Full Text] [Related]
34. Intratumoral CD8+ Lymphocyte Infiltration as a Prognostic Factor and Its Relationship With Cyclooxygenase 2 Expression and Microsatellite Instability in Endometrial Cancer.
Suemori T; Susumu N; Iwata T; Banno K; Yamagami W; Hirasawa A; Sugano K; Matsumoto E; Aoki D
Int J Gynecol Cancer; 2015 Sep; 25(7):1165-72. PubMed ID: 26111272
[TBL] [Abstract][Full Text] [Related]
35. Ki 67 is an independent predictive biomarker of cancer specific and local recurrence-free survival after lung tumor ablation.
Sofocleous CT; Garg SK; Cohen P; Petre EN; Gonen M; Erinjeri JP; Downey RJ; Travis WD; Solomon SB
Ann Surg Oncol; 2013 Dec; 20 Suppl 3(Suppl 3):S676-83. PubMed ID: 23897007
[TBL] [Abstract][Full Text] [Related]
36. Loss of membranous Ep-CAM in budding colorectal carcinoma cells.
Gosens MJ; van Kempen LC; van de Velde CJ; van Krieken JH; Nagtegaal ID
Mod Pathol; 2007 Feb; 20(2):221-32. PubMed ID: 17361206
[TBL] [Abstract][Full Text] [Related]
37. A cohort study of STMN1 expression in colorectal cancer: body mass index and prognosis.
Ogino S; Nosho K; Baba Y; Kure S; Shima K; Irahara N; Toyoda S; Chen L; Kirkner GJ; Wolpin BM; Chan AT; Giovannucci EL; Fuchs CS
Am J Gastroenterol; 2009 Aug; 104(8):2047-56. PubMed ID: 19513025
[TBL] [Abstract][Full Text] [Related]
38. Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer.
Baba Y; Nosho K; Shima K; Freed E; Irahara N; Philips J; Meyerhardt JA; Hornick JL; Shivdasani RA; Fuchs CS; Ogino S
Clin Cancer Res; 2009 Jul; 15(14):4665-73. PubMed ID: 19584150
[TBL] [Abstract][Full Text] [Related]
39. Aspirin use and risk of colorectal cancer according to BRAF mutation status.
Nishihara R; Lochhead P; Kuchiba A; Jung S; Yamauchi M; Liao X; Imamura Y; Qian ZR; Morikawa T; Wang M; Spiegelman D; Cho E; Giovannucci E; Fuchs CS; Chan AT; Ogino S
JAMA; 2013 Jun; 309(24):2563-71. PubMed ID: 23800934
[TBL] [Abstract][Full Text] [Related]
40. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.
Mima K; Nishihara R; Qian ZR; Cao Y; Sukawa Y; Nowak JA; Yang J; Dou R; Masugi Y; Song M; Kostic AD; Giannakis M; Bullman S; Milner DA; Baba H; Giovannucci EL; Garraway LA; Freeman GJ; Dranoff G; Garrett WS; Huttenhower C; Meyerson M; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S
Gut; 2016 Dec; 65(12):1973-1980. PubMed ID: 26311717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
